Vinorelbine, Epirubicin, and Methotrexate (VEM) as Primary Treatment in Locally Advanced Breast Cancer

20016 citationsJournal Articlebronze Open Access

Authors

Jitka Abrahámová · Thomayer University Hospital

M Wagnerová · Univerzitná Nemocnica Louisa Pasteura

Eugen Kubala · Thomayer University Hospital

Vladimír Malec

Е. Симова · University of Žilina

I Siraková · Regional Museum and Gallery Jicin

Е.П. Павликова

Daniela Machová

Abstract

VEM represents an effective regimen for patients with locally advanced breast cancer, allowing an important pCR. Moreover, this regimen appears to be particularly well tolerated.

Topics & Keywords

Breast Cancer Treatment Studies Cancer Treatment and Pharmacology Breast Lesions and Carcinomas

UN Sustainable Development Goals

Life in Land

Publication Details

Published in: The Oncologist

Volume 6, Issue 4, pp. 347-352

DOI: 10.1634/theoncologist.6-4-347

Field-Weighted Citation Impact: 0.25